ARIES-HM3 Trial: In patients with HF receiving HM3 LVAD, VKA alone without aspirin results in no change in thrombotic outcomes, significantly less bleeding and less hospitalizations.
Download slides for the ARIES-HM3 trial on excluding aspirin in LVAD HM3 presented at #AHA23 Link here: https://t.co/1VAuUj8Wnz
I’m honored and humbled to have received the news that my @alzassociation Research Fellowship to promote diversity has been funded! Thank you to all my mentors, Dr. Lydia Bazzano, David Libon, Rhoda Au, and @vkola_lab .
Editor's Choice in J Alzheimers Dis.
Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study https://t.co/BZuDZyFcTv
Thank you @StavrosDrakos for visiting @UCSDCardiology and giving an excellent Grand Rounds on Myocardial Recovery. I’m looking forward to seeing the continued impact of this innovative work on our vulnerable HF patients!
So proud to be w @UCSDCardiology AHF/TC! 89 🫀 txp, #4 in the nation by volume, incredible 30d and 1y survival outcomes. Life changing therapies for patients and their families! Excited for 2023!
Super excited and honored to have matched @UCSDHealth - Advanced Heart Failure/Transplant Cardiology. Looking forward to a great year! @HowieTranMD@EricAdler17 @pjkim08